Phase I Study of Intraperitoneal (IP) Denileukin Diftitox (ONTAK) in Patients with Advanced Ovarian Cancer (OC)

Posters
2008
TVG Tumor-Immune Environments
Salazar LG, Dang Y, Wallace D, Swensen R, Markle V, Coveler AL, Royer B, Slota M, Childs J, Bates N, and Disis ML